- Report
- January 2022
- 139 Pages
Global
From €3025EUR$3,400USD£2,612GBP
- Report
- March 2021
- 137 Pages
Global
From €4359EUR$4,900USD£3,764GBP
- Report
- February 2021
- 80 Pages
India
From €1059EUR$1,190USD£914GBP
- Report
- January 2021
- 109 Pages
Global
€3990EUR$4,804USD£3,566GBP
- Report
- December 2020
- 20 Pages
United States
€1379EUR$1,550USD£1,191GBP
- Report
- January 2024
- 101 Pages
Global
From €3500EUR$4,214USD£3,128GBP
- Webinar
- 60 Minutes
Global
From €133EUR$150USD£115GBP
- Book
- February 2025
- 432 Pages
- Book
- February 2023
Global
- Book
- March 2023
North America
The COVID 19 Vaccine market is a rapidly growing sector of the Vaccines industry. It is driven by the urgent need to develop a safe and effective vaccine to protect against the novel coronavirus. Companies in the market are working to develop and manufacture vaccines that can be used to protect people from the virus. Vaccines are being developed using a variety of technologies, including mRNA, DNA, and viral vector-based approaches.
The COVID 19 Vaccine market is highly competitive, with many companies vying for a share of the market. Companies are investing heavily in research and development to develop vaccines that are safe and effective. They are also investing in manufacturing and distribution capabilities to ensure that the vaccines can be quickly and efficiently delivered to those who need them.
Some of the companies in the COVID 19 Vaccine market include Pfizer, Moderna, Johnson & Johnson, AstraZeneca, Novavax, and Sanofi. These companies are working to develop and manufacture vaccines that can be used to protect people from the virus. Show Less Read more
